Hepatocarcinogenesis Risk Diagnostic Markers

Fibulin3 and GPNMB in serum of patients with MASLD as a direct biomarkers for assessing the risk of developing liver cancer.

X-ray microscopes with high robustness and reduced costs for design, manufacturing, installation, and maintenance

Bone Formation Promoter for Fractures, Spinal Fixation, Osteoporosis

A complex of bone morphogenetic protein (BMP2, FGF2, etc.) and polysulfated glycopeptide promotes bone formation by specifically delivering, accumulating, and maintaining the concentration of BMP2 on the bone surface.

Protocol for induction of Plateable primary hepatocytes from Suspension-type

A combination of extracellular matrix (ECM) and supplements can obtain highly useful plateable human primary hepatocytes from inexpensive suspension-type

Anti-miRNA Anticancer Drugs

Improved S-TuD (Synthetic Tough Decoy) RNA nucleic acid that inhibits miR-200 family, which is highly expressed in mammary cancer, colon cancer, endometrial cancer, ovarian cancer, etc.

Combination of IDO1 and COX2 inhibitors for cancer treatment

Focus on immune evasion mechanisms and cancer metabolism

Fusion Protein Anticancer Drug Targeting RAS

Fusion protein X, which combines a RAS-binding domain, a cell membrane-permeable peptide, and a third domain, inhibits the function of activated RAS and degrades it.

DHODH inhibitors for a wide range of viral infections

New concept to deplete the cellular nucleic acid pool against transient nucleic acid demand during viral replication

The Attachment for plate culture to assess cell-microbe interactions

Amino Acid Prodrug to Increase Muscle Mass and Enhance Exercise Performance

Orally available micelle-type branched-chain amino acid prodrug